1281125

Boehringer Ingelheim Pharmaceuticals, Inc. — FEI 1219205

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 11, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Ridgefield, CT (United States)

Additional Details

Sponsor, Contract Research Organization

Citations

IDCFRDescription
748021 CFR 312.50Ensuring compliance with plan and protocol